A068760 Stock Overview
A pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Celltrion Pharm, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩57,100.00 |
| 52 Week High | ₩133,300.00 |
| 52 Week Low | ₩52,000.00 |
| Beta | 0 |
| 11 Month Change | -11.61% |
| 3 Month Change | -20.91% |
| 1 Year Change | -32.56% |
| 33 Year Change | -46.50% |
| 5 Year Change | 87.18% |
| Change since IPO | 396.53% |
Recent News & Updates
Does Celltrion Pharm (KOSDAQ:068760) Deserve A Spot On Your Watchlist?
May 05
Do Institutions Own Celltrion Pharm, Inc. (KOSDAQ:068760) Shares?
Mar 03These 4 Measures Indicate That Celltrion Pharm (KOSDAQ:068760) Is Using Debt Reasonably Well
Feb 02
Recent updates
Does Celltrion Pharm (KOSDAQ:068760) Deserve A Spot On Your Watchlist?
May 05Do Institutions Own Celltrion Pharm, Inc. (KOSDAQ:068760) Shares?
Mar 03These 4 Measures Indicate That Celltrion Pharm (KOSDAQ:068760) Is Using Debt Reasonably Well
Feb 02Do Celltrion Pharm's (KOSDAQ:068760) Earnings Warrant Your Attention?
Dec 29Celltrion Pharm, Inc.'s (KOSDAQ:068760) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Nov 24Shareholder Returns
| A068760 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 3.4% | -9.2% | -2.8% |
| 1Y | -32.6% | 8.0% | -3.4% |
Return vs Industry: A068760 underperformed the KR Pharmaceuticals industry which returned 8% over the past year.
Return vs Market: A068760 underperformed the KR Market which returned -3.4% over the past year.
Price Volatility
| A068760 volatility | |
|---|---|
| A068760 Average Weekly Movement | 4.2% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in KR Market | 11.5% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A068760 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A068760's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1976 | n/a | Jung-su Seo | www.celltrionph.com |
Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies.
Celltrion Pharm, Inc. Fundamentals Summary
| A068760 fundamental statistics | |
|---|---|
| Market cap | ₩2.37t |
| Earnings (TTM) | ₩26.03b |
| Revenue (TTM) | ₩274.73b |
0.0x
P/E Ratio0.0x
P/S RatioIs A068760 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A068760 income statement (TTM) | |
|---|---|
| Revenue | ₩274.73b |
| Cost of Revenue | ₩193.89b |
| Gross Profit | ₩80.84b |
| Other Expenses | ₩54.82b |
| Earnings | ₩26.03b |
Last Reported Earnings
Mar 31, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A068760 perform over the long term?
See historical performance and comparison